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Salmonella Typhi is a human-restricted bacterial pathogen that causes typhoid fever, a
life-threatening systemic infection. A fundamental aspect of S. Typhi pathogenesis is its
ability to survive in human macrophages but not in macrophages from other animals
(i.e. mice). Despite the importance of macrophages in establishing systemic S. Typhi
infection, the mechanisms that macrophages use to control the growth of S. Typhi and the
role of these mechanisms in the bacterium’s adaptation to the human host are mostly
unknown. To facilitate unbiased identification of genes involved in controlling the growth of
S. Typhi in macrophages, we report optimized experimental conditions required to
perform loss-of function pooled shRNA screens in primary mouse bone-marrow
derived macrophages. Following infection with a fluorescent-labeled S. Typhi, infected
cells are sorted based on the intensity of fluorescence (i.e. number of intracellular
fluorescent bacteria). shRNAs enriched in the fluorescent population are identified by
next-generation sequencing. A proof-of-concept screen targeting the mouse Rab
GTPases confirmed Rab32 as important to restrict S. Typhi in mouse macrophages.
Interestingly and rather unexpectedly, this screen also revealed that Rab1b controls S.
Typhi growth in mouse macrophages. This constitutes the first report of a Rab GTPase
other than Rab32 involved in S. Typhi host-restriction. The methodology described here
should allow genome-wide screening to identify mechanisms controlling the growth of S.
Typhi and other intracellular pathogens in primary immune cells.
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Upon bacterial invasion, cells of the innate immune system such
as macrophages act as the first line of defense to control the
infection. Macrophages are equipped with an array of
antimicrobial factors, allowing them to efficiently eliminate
invaders (Weiss and Schaible, 2015). However, some bacterial
pathogens have evolved mechanisms to resist the attack by
macrophages and adopt an intracellular lifestyle, persisting
inside these cells. The Gram-negative pathogen Salmonella
enterica, upon internalization by a host cell, establishes an
intracellular niche by creating a specialized compartment
known as Salmonella-containing vacuole where the bacterium
survives and replicates. The capability of Salmonella to exploit
and survive within macrophages is essential for its pathogenesis
and for the establishment of systemic infection (Fields et al.,
1986). This intracellular survival is made possible by the action of
type-III secretion systems (T3SS) that inject effector proteins into
target cells to manipulate host pathways. Salmonella encodes two
T3SS within the pathogenicity islands 1 (SPI-1) and 2 (SPI-2).
Some of these effectors block specific macrophage killing
mechanisms while others facilitate bacterial invasion and create
a habitable intracellular niche (Galán et al., 2014; Spanò et al.,
2016; Jennings et al., 2017).
The species Salmonella enterica comprises several serovars
and while most can infect a broad range of mammalian species,
others are host specific or host-restricted. Salmonella enterica
serovar Typhi (S. Typhi) is a host-restricted serovar that only
infects humans (Dougan and Baker, 2014) and causes the life-
threatening condition typhoid fever, resulting in between 11.9
and 26.9 million annual cases around the globe (Gibani et al.,
2018). The failure of this pathogen to infect other species is
partially due to its inability to overcome a host defense
mechanism, which depends on the Rab GTPase Rab32 and its
nucleotide exchange factor Biogenesis of Lysosome-related
Organelles Complex-3 (BLOC-3) (Spanò and Galán, 2012;
Spanò et al., 2016). This pathway is efficiently disarmed by the
broad-host serovar S. Typhimurium through the delivery of two
T3SS effectors: GtgE and SopD2. Both act directly on Rab32,
GtgE is a protease and SopD2 is a GTPase activating protein
(Spanò et al., 2016). In S. Typhi GtgE is absent while SopD2 is
a pseudogene.
Rab GTPases are key regulators of vesicle trafficking between
organelles and an interface between the host cell and the
internalized pathogen. Thus, it is not surprising that successful
intracellular pathogens use the manipulation of these proteins as
a mechanism to survive within their eukaryotic hosts (Bakowski
et al., 2010; Seto et al., 2011; Hardiman et al., 2012; McGourty
et al., 2012; Stein et al., 2012; Spanò and Galán, 2018). Despite
efforts to understand the nature of S. Typhi host-restriction, most
of our knowledge of Salmonella interactions with Rab GTPases is
extrapolated from S. Typhimurium studies, and many questions
as to how macrophages deal with S. Typhi remain open. In this
study, using a loss-of-function shRNA-based approach, we have
performed a screen in mouse bone-marrow derived
macrophages and identified Rab1b as a factor controlling S.
Typhi growth in mouse macrophages.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2MATERIALS AND METHODS
Bacterial Strains and Mammalian
Cell Culture
The S. Typhi wild-type ISP2825 (Galán and Curtiss, 1991) and
the S . Typhi glmS::Cm::mCherry (S . Typhi::mCherry)
(Baldassarre et al., 2021) strains have been described previously.
Salmonella can induce caspase 1-dependent macrophage
death (Brennan and Cookson, 2000). To avoid this, bone-
marrow-derived macrophages (BMDMs) were isolated from
caspase 1-deficient mice (casp1-/-) and differentiated as
described before (Weischenfeldt and Porse, 2008).
Immortal ized bone-marrow-derived macrophages
(iBMDMs), RAW264.7 and HEK293T cell lines were routinely
maintained in DMEM high glucose 2 mM glutamax (Thermo
Fisher) and 10% FBS (Gibco).
Infection of Macrophages With Salmonella
Typhi for Intracellular Survival Assays
(CFU Assay)
Overnight cultures of Salmonella were diluted 1/20 in LB broth
containing 0.3 M NaCl and grown at 37°C to an OD600 of 0.9.
Cells were washed twice with HBSS (Thermo Fisher) and
infected with S. Typhi at the indicated multiplicity of infection.
One hour post-infection, cells were washed twice with HBSS and
incubated in growth medium supplemented with 100 µg/ml
gentamicin for 30 min to kill extracellular bacteria. Then,
medium was replaced with growth medium containing 5 µg/ml
of gentamicin to avoid cycles of reinfection. At the indicated
times-post infection, cells were washed twice with PBS, lysed in
1 ml 0.1% sodium deoxycholate (Sigma) in PBS and intracellular
bacteria counted by plating serial dilutions on LB-agar plates.
Salmonella Typhi Infection of
Macrophages for Flow-Cytometry
and Fluorescence Microscopy
To determine the optimal multiplicity of infection (MOI), 6x105
BMDMs were plated on 6-well plates and infected with different
amount of fluorescent bacteria (from MOI 5 to 30). One hour-
post infection, medium was replaced with medium containing
100 µg/ml gentamicin for 30 minutes and cells were collected by
incubating with cold Versene (Gibco) for 5 minutes, fixed with
4% paraformaldehyde (PFA) for 10 minutes at room
temperature and analyzed using the Fortessa flow cytometer.
In parallel, 1x105 BMDMs were plated on 24-well plates and
infected as before. Cells were then fixed with 4% PFA and
visualized with a Zeiss Imager M1 fluorescence microscope.
For quantification of the number of bacteria per cell, a
minimum of 72 infected cells were analyzed per condition and
the results plotted with Prism 8.
To confirm that shRNA-mediated gene knockdown resulted
in a measurable phenotype, 4x106 BMDMs were transduced with
shRNAs targeting HPS-1 or scrambled sequence and plated on 6-
well plates (6x105 cells/well; flow cytometry) or 24-well plates
(1x105 cells/well; fluorescence microscopy and CFU assays).
After selection with puromycin, transduced cells were infected
with S. Typhi::mCherry and samples at 1.5, 5 and 24 hours post-April 2021 | Volume 11 | Article 660689
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microscopy as described above. For quantification of the
number of bacteria per cell, a minimum of 100 cells were used
per condition and the results plotted with Prism 8.
RNA Isolation and RT-qPCR
Total RNA from eukaryotic cells was isolated using the RNeasy
mini kit (QIAGEN). RNA was transcribed using the iScript
reverse transcriptase (BioRad) and transcript levels were
determined using the Takyon SYBR MasterMix (Eurogentec)
and the StepOnePlus real-time PCR system (Applied
BioSciences). Primers are listed in Table S5.
Generation of Rab GTPases shRNA Library
and Screening
The mouse Rab GTPases shRNA library (317 shRNAs) was
extracted from The Mission mouse shRNA library generated by
The RNAi consortium (Sigma Aldrich) and prepared as
described before (Shi et al., 2016). The shRNA targeting the
HPS-1 gene as well as the packaging plasmids pCMV-VSV-G
and pCMV-dR8.91 were obtained from Sigma Aldrich. The
plasmids encoding the shRNA sequences were pooled in equal
concentrations and mixed with pCMV-VSV-G (1:0.1) and
pCMV-dR8.91 (1:1) to generate lentiviral particles. HEK293T
cells were transfected with the plasmid mixture and
polyethyleneimine as transfecting reagent. Fifty-two hours
post-transfection, the lentivirus particles were collected from
cell supernatants.
Three independent experiments were performed and sorted
independently. For each, a total of 1x107 BMDMs were transduced
at day 4 after isolation for 24 hours and selected in puromycin
(5 µg/ml) for 48 hours. Cells were then infected with S. Typhi::
mCherry at an MOI of 10. At 1.5 and 24 hours-post infection, cells
were processed for flow cytometry as described above. A total of
50,000 cells (N and M populations) or 17,000 to 20,000 cells (H
population) were sorted in a BD Influx BSLII Sorter (Iain Fraser
Cytometry Centre, University of Aberdeen) (Figure S3). Genomic
DNA (gDNA) was isolated using the DNeasy Blood & Tissue kit
(QIAGEN) following the instructions of the manufacturer with
the following modifications: after cell lysis, samples were incubated
at 90°C for 1 hour to reverse PFA modification of DNA. The
resulting gDNA was used as template for PCR amplification of the
shRNA-encoding regions using the Fw-NGS and the Rev-NGS
primers (IDT Technologies) and the Phusion High Fidelity DNA
polymerase (NEB). Three PCRs per condition were performed and
the amplicons combined. Primer sequences are listed in Table S5.
A second PCR was performed to attach indexes and Illumina
adaptors and the PCR amplicon was sequenced on the
NextSeq500 v2 instrument (Centre for Genome-Enabled Biology
and Medicine (CGEBM), University of Aberdeen).
Data Analysis
The analysis of the data involved background correction and
scoring. Firstly, the proportion of reads relative to total reads of
each shRNA was obtained using the BBDUK software (CGEBM,
University of Aberdeen). shRNAs with value “0” in 2 out of the 3
experiments in the plasmid library or controls (non-sorted cells) atFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3either 1.5 and 24 hours-post infection were excluded from the
analysis (Table S2). Then, the proportion of reads of each shRNA
within the high fluorescence population (H) relative to the total
proportion of reads (H, M and N populations) was calculated as
well as the average and standard deviation of the population. Finally,
the z-score for each shRNA was calculated as z = (x-m)/s, where x is
the value obtained of each shRNA (proportion of reads of each
shRNA within the high fluorescence population (H) relative to the
total reads (N+M+H), m is the population mean and s is the
standard deviation of the population (Table S3). True hits were
defined as those for which at least 2 shRNAs had a z-score ≥1.18
based on the scores obtained for internal positive controls
(Table S4).
Validation of Candidate Genes by
Individual Gene Knockdown and
Intracellular Survival Assay
iBMDMs were transduced with lentivirus encoding shRNA to
knockdown individually candidate genes 6 days before infection.
Twenty-four hours after transduction, cells were incubated with
5 µg/ml puromycin for 2-4 days. S. Typhi infection assays were
carried out as described before.RESULTS
shRNA-Mediated Knockdown in
Bone-Marrow Derived Macrophages
Pooled shRNA screens offer unbiased approaches to identify genes
important for specific biological processes (Silva et al., 2008;
Carette et al., 2011). As illustrated in Figure 1, we designed an
shRNA screening strategy to identify macrophage proteins whose
knockdown facilitated S. Typhi growth. The approach requires
efficient delivery of the shRNA library into primary macrophages
to generate a pool of knockdown cells coupled with an effective
sorting strategy to collect cells that failed to clear the invading
bacteria. As described below we optimized each of these steps.
Loss of function screenings in primary macrophages require
optimization of conditions to achieve efficient and reproducible
gene knockdown within the macrophage lifespan and without
affecting their final differentiation. Although several methods to
introduce exogenous DNA in primary murine macrophages have
been reported (Thompson et al., 1999; Guiet et al., 2012),
lentiviral systems have been shown to be the most efficient
method (Naldini et al., 1996; Schroers et al., 2000). While Zeng
et al., have shown that culturing macrophages for 8 days in vitro
increased the transduction efficiency using HIV-based vectors
(Zeng et al., 2006) others recommended earlier stages of
differentiation for efficient transduction (Miller and Blystone,
2015). In order to determine, under our experimental conditions,
the optimal post-isolation day to transduce BMDMs, we used a
lentivirus encoding a puromycin resistance marker and
transduced BMDMs that were in culture from day 4 to day 9
of differentiation. Transduced cells were selected with 5 µg/ml
puromycin for 48 hours and cell survival determined by alamar
blue assay. The results obtained showed that at the early stages of
the differentiation into macrophages (day 4), cells are transducedApril 2021 | Volume 11 | Article 660689
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Importantly, the level of transduction achieved (≈60%) ensured
that the probability of having a cell infected by more than one
virus (i.e. more than one shRNA) is low.
We then confirmed that the viral transduction process did not
affect the ability of mouse macrophages to control S. Typhi
growth. Indeed, BMDMs transduced at day 4 with a virus
encoding a non-targeting shRNA scrambled sequence (SCR)
are still able to control S. Typhi growth (Figure 2B). Next, we
knocked-down HPS-1 (≈95% knockdown; Figure S1) in
BMDMs. HPS-1 is one of the two subunits of the BLOC-3
complex, which together with Rab32, controls S. Typhi growth
in macrophages (Spanò and Galán, 2012; Baldassarre et al.,
2021). We assessed S. Typhi intracellular survival in
HPS-1-depleted macrophages using CFU assays (Figure 2B),
flow cytometry (Figure 2C) and fluorescence microscopy
(Figure S2). After infection with S. Typhi::mCherry, samples
were analyzed at three different times post-infection: 1.5
(internalized bacteria), 5 and 24 hours. As shown in Figure2C,
at 24 hours post-infection, there is a population representing
1.34% of the HPS-1-depleted cells containing higher loads of
intracellular bacteria, while this population only represents 0.4%
of the control cells. Similarly, the analysis by fluorescence
microscopy showed that the number of intracellular bacteria
per cell significantly increased at late time points in HPS-1
knockdown cells but not in control cells (Figure S2).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4Even though we cannot exclude subtle changes, these data
confirmed that viral-delivered shRNAs per se do not affect the
macrophages ability to restrict S. Typhi and that shRNA-
dependent gene knockdown results in an assessable phenotype
in BMDMs.
Flow Cytometric Analysis of S. Typhi
Infection in BMDMs
Our screening approach relies on an efficient flow cytometric
method to detect and isolate cells that, upon gene silencing, are
more permissive to S. Typhi growth. However, if a macrophage
lacks a factor required to control the growth of S. Typhi,
replication of the bacteria within the cell could ultimately lead to
cell death and loss of a positive hit. To limit this, we have
optimized the ratio of bacteria/cell during the infection
(multiplicity of infection; MOI) in order to obtain a reasonable
infection rate (50-60% infected cells) with low numbers of bacteria
in each infected cell (2-3 bacteria per cell). For this, BMDMs were
infected with different amounts of S. Typhi::mCherry, fromMOI 5
to 30. One-hour post infection, cells were treated with gentamicin
for 30 minutes to kill any extracellular bacteria, fixed and the
percentage of infected cells, as well as the number of bacteria per
cell, was determined by fluorescence microscopy (Figure 2D) and
flow cytometry (Figure 2E). When cells were infected with an
MOI of 5, the mean number of intracellular bacteria was 2 and the
percentage of infected cells was around 30% (42.2% flowFIGURE 1 | shRNA screening in BMDMs. Schematic representation of the experimental approach of the shRNA screening in BMDMs. BMDMs were isolated from
casp1-/- mice and transduced at day 4 after isolation. After selection with puromycin for 48 hours, cells were infected with S. Typhi::mCherry. At 1.5 and 24 hours
post-infection cells were fixed with 4% PFA and the different sub-populations sorted based on dsRed fluorescence (gates for the different sub-populations indicated).
Genomic DNA from sorted and non-sorted cells (control) was isolated, the region encoding the shRNA amplified by PCR and the amplicons sequenced by next-
generation sequencing (NextSeq500). As a result of the screen, 11 candidate genes were identified based on a z-score >1.18 and hits validated using shRNAs to
knockdown the individual genes.April 2021 | Volume 11 | Article 660689





FIGURE 2 | shRNA-mediated knockdown in BMDMs. (A) BMDMs were transduced at different days post-isolation. After incubation with 5 mg/ml puromycin for 48
hours, cell viability was evaluated with alamar blue assay. Percentage of survival are: Day 4 67.72%, Day5 26.84%, Day 7 25.02%, Day 9 9.63%. Values are mean ±
SEM of two independent measurements. NS, non-significant; *P < 0.05; **P < 0.01; ***P < 0.005. (B) BMDM cells were transduced with lentiviral particles encoding
a non-target scrambled sequence (SCR) or encoding a sequence targeting HPS-1 (HPS-1 KD). After selection with 5 µg/ml puromycin, cells were infected with
S. Typhi wild-type, lysed at three times post-infection (1.5, 5 or 24 h) and CFUs were enumerated. Values are means ± SEM of two independent experiments
performed in triplicate. P values were determined by the Student´s t test and are indicated when P < 0.05. (C) BMDMs HPS-1 Knockdown (HPS1 KD) or control
(Scrambled shRNA; SCR) were infected with S. Typhi::mCherry (MOI 10). At different times post-infection (1.5, 5 and 24 hours post-infection), cells were fixed with
4% PFA and analyzed by flow cytometry. The three subpopulations non-infected (N) (red), 1-3 bacteria (M) (blue) and >3 bacteria (H) (yellow) are shown and the
percentage of the M and H populations are indicated. (D, E) BMDMs were infected with S. Typhi::mCherry at different multiplicity of infection (MOI). After 1.5 hours-
post infection, cells were fixed with 4% PFA and analyzed by fluorescence microscopy (D) or flow cytometry (E) to determine the percentage of infected cells and
the average number of bacteria per cell. For quantification of the number of bacteria per cell for fluorescence microscopy, 85 (out of 272 total; MOI 5), 83 (out of 190
total; MOI 10), 72 (out of 147 total; MOI 15), 80 (out of 128 total; MOI 20) and 88 (out of 122 total; MOI 30) infected cells were analyzed.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org April 2021 | Volume 11 | Article 6606895
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infected cells increased to 44% (55% flow cytometry) and only 9
out of 83 infected cells contained more than 4 intracellular
bacteria. Higher MOI resulted in higher number of infected cells
(from 42.2% to 80.1%) but the number of bacteria per cell
increased notably as well, finding a considerable number of cells
with more than 6 bacteria per cell with the highest MOI
(Figure 2D). Therefore, all subsequent experiments were
performed using an MOI of 10. In addition, these analyses
allowed us to determine the sensitivity of the flow cytometer.
Cells with as few as 1-2 fluorescent intracellular bacteria were
detectable as an independent population easily distinguishable
from non-infected cells (Figure 2E).
shRNA Screen of Rab GTPases Involved
in S. Typhi Growth Restriction in
Mouse Macrophages
To validate our screening strategy and to identify novel Rab
GTPases involved in restricting the growth of S. Typhi in
macrophages, we performed a targeted loss-of-function shRNA
screen in BMDMs using a custom-made pooled library
(Table S1; summarized in Figure 1). We also included a
validated shRNA targeting HPS-1 as an internal positive control.
Three independent screens were performed. For each one,
1x107 BMDMs were transduced at 4 day after isolation with a
pool of lentiviruses encoding the library and the positive control
(see Materials and Methods). After 48 hours of selection with 5
µg/ml puromycin, transduced macrophages were infected with S.
Typhi::mCherry at MOI 10. One hour after infection, the
medium was replaced with fresh medium containing 100 µg/
ml gentamicin for 30 min. At 1.5- and 24-hours post-infection,
cells were lifted from the plates, fixed with 4% PFA and the
different sub-populations of cells sorted based on red-
fluorescence using an strategy that enabled enrichment of the
very low abundant population containing more than 3 bacteria
(an example is shown in Figure S3). Based on our fluorescence
experiments, the sorted populations contains on average no
bacteria (N), 1-3 bacteria (M) and >3 bacteria (H).
Once sorted, the genomic DNA from each cellular sub-
population was isolated, the regions containing the shRNA
sequences were PCR-amplified and the amplicons subjected to
next-generation sequencing. Amplicons obtained from both the
plasmid library and non-sorted cells were sequenced and used as
controls to determine i) the abundance of each shRNA in the
initial plasmid pool, ii) whether a particular hairpin present in
the plasmid library was lost after transduction (absent from non-
sorted 1.5 hours post-infection sample) and iii) whether a
hairpin was lost over time independently of the infection
(absent from non-sorted 24 hours post-infection sample)
(Figure 1 and Table S2).
Out of the 318 shRNAs that comprised the library, 7 shRNAs
were not present or not detected by deep sequencing (0 reads in
the plasmid library sample), 8 shRNAs were not present in non-
sorted samples at either 1.5 or 24 hours and the reads for 2
shRNAs were “0” in all the sub-populations in at least one full
experiment. All those shRNAs were not considered for further
analyses (Table S2). Using these criteria none of the 56 genesFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6included in the library were lost and at least 3 shRNAs per gene
were included in the analysis. To obtain the list of candidate genes
involved in S. Typhi growth-restriction and therefore those more
abundant in the H population (Figures 1 and S3), we first
calculated for each shRNA the total proportion of reads (N, M
and H) as well as the proportion of reads within the H sub-
population. Then, we calculated the percentage of reads in H
relative to total reads (N, M and H). Finally, we calculated the z-
score for each individual shRNA (see Materials and Methods,
Figure S3B and Table S3). By performing this analysis, the z-score
values obtained for the positive controls were: HPS-1, z = 1.22 and
Rab32 z = 1.18, z = 2.29, z = 0.63, z = -0.37 and z = -1.18). This
variation is expected since not all shRNA sequences will result in
knockdown. In view of the scores obtained for known positive hits,
we opted for a less stringent strategy in order to minimize the
chances of excluding positive candidates. Therefore, we selected
1.18 as threshold to call out hits and used the following criterion to
generate a candidate gene list: 2 or more shRNAs with a z-score
>1.18. Using this strategy we identified 11 candidate genes (≈20%
of the total genes) that are listed in Table S4.
Rab1b Is Important to Control S. Typhi
Growth in Mouse Macrophages
To prove the reproducibility of the data independently of the cell
model, we used immortalized BMDMs (iBMDMs) to validate
our hits. Additionally, this allowed us to reduce the use of
animals in line with the principles of the 3Rs (Replace, Reduce,
Refine). We first confirmed that iBMDMs behave similarly to
BMDMs in their ability to kill S. Typhi (Figure 3A). We also
confirmed that HPS-1 depleted iBMDMs are more permissive to
S . Typhi growth by CFU assays and flow cytometry
(Figures 3A, B). The results obtained showed that iBMDMs
could be used as a suitable cellular model to validate the
candidates from the shRNA screen.
For each candidate gene we took the second best shRNA
(Table S4) and checked the levels of knockdown achieved
(Figure S4). The reduction in mRNA expression was over 50%
in all cases except for Rab27 and Rab40c. Furthermore, Rab25
mRNA was not detectable. This suggested that these three Rabs
were false positives and were removed from our validation list. We
then measured the CFUs 24 hours after infection with S. Typhi::
mCherry (Figure 4). As expected, we confirmed that depletion of
Rab32 and HPS-1 in mouse macrophages lead to an increased
survival of S. Typhi (Spanò and Galán, 2012). Among the other 7
Rab GTPases tested, only the knockdown of Rab1b showed a
significant increase of S. Typhi survival (Figure 4). It is extremely
unlikely that two different shRNA sequences produce the same off-
target phenotype; therefore, we tested the other Rab1b shRNA
(Rab1b#1; z-score=1.78). The results obtained were similar to
those reported above and are shown in Figure 4.DISCUSSION
Unbiased genetic screenings have been crucial to identify host
genes that play important roles in dealing with infections (Zhou
et al., 2012; Li et al., 2017; Yeung et al., 2019). However, as primaryApril 2021 | Volume 11 | Article 660689
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propagated in culture, the majority of these screens have been
performed in alternative cell lines. Cell lines have the advantages of
being easier to manipulate genetically and more straightforward to
expand in culture, but their continuous subculture can lead to
altered macrophage functions, including pathogen killing, limiting
their suitability for screening experiments.
In this study, we performed a loss-of-function screen in
primary mouse macrophages using viral-delivered shRNAs inFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7the context of S. Typhi infection. To the best of our knowledge,
this screen is the first of its kind. We have shown that viral-
delivered shRNAs represent a good method to achieve sufficient
level of knockdown for further phenotypic analyses. Importantly,
we have developed a protocol that allows sorting and extracting
good quality DNA from fixed cells for further next-generation
sequencing. This is important due to the restrictions of working
with S. Typhi, which in many places requires containment level 3
(CL3) facilities. Therefore, by fixing the samples we eliminated
the requirement of a cell sorter in CL3 environment.
Our fluorescence microscopy and flow cytometry analyses of
HPS-1-depleted macrophages in response to S. Typhi infection
showed that the removal of HPS-1 led to a population of
macrophages containing very high numbers of bacteria (>6), but
also induced a shift in the intermediate population with more cells
containing between 3 and 6 bacteria (Figures 2C and S2).
Therefore, we selected a gate that includes both the very low
abundant population containing a very high number of bacteria
and the upper limit of the population containing lower numbers of
intracellular bacteria (Figure S3A, gate H). This slightly more
inclusive gating also allowed us to reduce the total number of cells
to be sorted in order to recover enough cells from the H population
for further analyses. The down side of this expansion is thatwe have
probably increased the number of false positives. These aspects
should be taken into consideration when planning for screens with
larger libraries. Alternatives, such asperforming ahigher stringency
secondary screen with libraries targeting the hits identified with a
first low stringent strategy, should be carefully considered.
In addition to providing a proof-of-concept study, our screen
revealed that Rab1b is important to control the growth ofA B
FIGURE 3 | Depletion of HPS-1 allows S. Typhi to survive better in immortalized bone-marrow-derived macrophages (iBMDMs). (A) BMDMs, iBMDMs or iBMDMs
HPS-1 knockdown (HPS-1 KD) were infected with S. Typhi wild-type (MOI 5). At the indicated times post-infection, cells were lysed and CFU enumerated. The CFUs
obtained are normalized against the first time point 1.5 hpi, which is considered as 100% of uptake. Values are means ± SEM of two independent experiments
performed in triplicates. P values were determined by the Student´s t test: ***, P < 0.005. (B) iBMDMs transduced with lentivirus encoding either non-targeting
sequences (CTR) or an shRNA targeting HPS-1 (HPS-1 KD) were infected with S. Typhi::mCherry. At different times post-infection (1.5 or 24 hpi) cells were fixed and
analyzed by flow cytometry. The abundance in percentage of the different subpopulations is indicated.FIGURE 4 | Validation of candidate genes. For each gene, lentiviral particles were
generated and used to transduced iBMDMs. After selection with 5 µg/ml puromycin
for 48 hours, cells were infected with S. Typhi::mCherry. At different times post-
infection (1.5 and 24 hours), cells were lysed and CFUs enumerated. The CFUs
obtained were normalized against 1.5 hpi and the data represent the fold-survival of
the bacteria relative to in control (CTR) cells. Values are means ± SEM of at least
two independent experiments performed in triplicates. P values were determined by
the Student´s t test: **P < 0.01; ****P < 0,001. NS, non-significant.April 2021 | Volume 11 | Article 660689
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vesicle transport from the endoplasmic reticulum (ER) to the
Golgi (Plutner et al., 1991). Moreover, Rab1 is involved in
autophagy, a process by which the cell delivers cytosolic
material (misfolded proteins, damaged organelles and
pathogens) to the lysosome for degradation (Kakuta et al.,
2017). In the context of bacterial infections, the active
recruitment of Rab1 to vacuoles containing Legionella
pneumophila or Yersinia pestis, prevents acidification of this
compartment and permits their survival inside macrophages
(Kagan et al., 2004; Connor et al., 2015). An siRNA screen in
epithelial cells identified Rab1 as a host factor that facilitates S.
Typhimurium intracellular growth (Thornbrough et al., 2012).
Recent studies have identified three S. Typhimurium effectors
neutralizing Rab1 functions: SseF and SseG block Rab1-mediated
autophagy (Feng et al., 2018) while SseK3 covalently modifies
Rab1 impairing ER-Golgi trafficking and limiting the secretion of
cytokines (Gan et al., 2020; Meng et al., 2020). The fact that a
pathogen uses multiple effectors to target a single host protein
highlights the importance of Rab1 in the context of Salmonella
infection. SseK3 is absent from S. Typhi while both SseG and
SseF are present (including in the strain used in this study) and
are 98.2% and 96.5% identical, respectively, to the S.
Typhimurium effectors. However, SseF has evolved differently
in different Salmonella serovars (Eswarappa et al., 2008) possibly
explaining why S. Typhi cannot block Rab1b in mouse cells.
In summary, we have described experimental conditions to
perform loss-of-function screens in primary macrophages
negotiating the constraints required by a CL3 environment.
This offers the potential to perform unbiased large-scale
screenings in primary macrophages to identify novel
mechanisms of pathogen killing. Interestingly, as a result of a
targeted screen, we have identified a role of Rab1b in controlling
the growth of S. Typhi in mouse macrophages. To the best of our
knowledge, this is the first report showing a Rab GTPase other
than Rab32 having a role in the restriction of S. Typhi in mice.
Future work will define how Rab1b prevents S. Typhi growth in
mouse macrophages and whether this strategy is related to other
previously described macrophage-killing mechanisms against
this human pathogen.AUTHOR´S NOTE
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